2 Significant Positive Events Aren’t Enough to Fix the Market
A Treasury intervention and 170% move in Moderna produced only a 0.2% gain in the S&P 500.
Scott Bessent’s Surprise Bond Move Helped, But Moderna Does the Heavy Lifting
The indices held up on one biotech breakthrough while the Nasdaq lost ground.
The Treasury Steps In, and I Ring the Register
I reduced three biotech winners, and not because I think they are going down.
A Shift in Market Character, Not a Collapse
Sustained upside is less likely from here, as rotation is starting to turn defensive.
Seasonal Slowdown Finally Arrives
The negative seasonality I have been anticipating finally kicked in on Tuesday.
I’m Stalking Amazon
The market is under pressure but buying opportunities are slowly developing; here’s how I’m trying to time an entry.
4 Issues Are Colliding to Test a Vulnerable Market
Global yields are surging as chip strength reverses and negative seasonality beckons.
Chip Strength Holds Up the Indices but Creates an Inflation Problem
Rotational action masked severe weakness as trading slowed.
A Small-Cap Stock Is Offering an Opportunity — And Almost Nobody Is Covering It
Amid ‘troubling’ market action Monday, here’s what to know about one of my top small-cap plays.
Anticipation of a Pullback Is Preventing … a Pullback
The bearish argument is logical, but price action refuses to confirm it. Here’s what could change things.